FDA Drug Application (021332) for SYMLIN by ASTRAZENECA AB

Back to FDA Applications sponsored by ASTRAZENECA AB

Application Number021332
Product Number001
FormINJECTABLE;SUBCUTANEOUS
DosageEQ 3MG BASE/5ML (EQ 600MCG BASE/ML)
Product Market Status Discontinued
Therapeutic Equivalence Evaluation Code
Reference Drug
Drug NameSYMLIN
Active IngredientPRAMLINTIDE ACETATE



Back to FDA Applications sponsored by ASTRAZENECA AB